VCM
TECH icon

Vigilant Capital Management’s Bio-Techne TECH Stock Holding History

Vigilant Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-48
Closed -$4K – 503
2022
Q4 		$4K Hold
48
– – ﹤0.01% 467
2022
Q3 		$3K Hold
48
– – ﹤0.01% 550
2022
Q2 		$4K Hold
48
– – ﹤0.01% 545
2022
Q1 		$5K Hold
48
– – ﹤0.01% 531
2021
Q4 		$6K Hold
48
– – ﹤0.01% 563
2021
Q3 		$6K Buy
+48
New +$5.84K ﹤0.01% 627

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vigilant Capital Management's TECH Position: Q1 2023 in Review

Vigilant Capital Management sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 48 shares — an estimated $4K sold.

Vigilant Capital Management first reported a position in TECH in Q3 2021 and held it in 6 quarters. The position peaked at $6K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • Vigilant Capital Management reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • Vigilant Capital Management sold 48 Bio-Techne shares in Q1 2023, an estimated $4K.
  • Vigilant Capital Management first reported a position in Bio-Techne in Q3 2021 and held it in 6 quarters.
  • Vigilant Capital Management's Bio-Techne position peaked at $6K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Vigilant Capital Management's 13F filing for Q1 2023, filed 1 May 2023.